Interim Results from the First-in-Human Clinical Trial of Adct-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody Drug Conjugate, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
• 作者

  Radford John; Kahl Brad S.; Hamadani Mehdi; Carlo-Stella Carmelo; Caimi Paolo; Ardeshna Kirit M.; Feingold Jay; He Shui; Reid Erin; Solh Melhem; Chung Ki-Young; Heffner Leonard; Ungar David; OConnor Owen A.;

  展开▼
• 作者单位

  Univ Manchester Manchester Acad Hlth Ctr Manchester Lancs England;

  Washington Univ Siteman Canc Ctr St Louis MO USA;

  Med Coll Wisconsin Div Hematol &

  Oncol Milwaukee WI 53226 USA;

  Humanitas Canc Ctr Hematol Rozzano Italy;

  Case Western Reserve Univ Univ Hosp Cleveland Cleveland OH 44106 USA;

  Univ Coll London Hosp NHS Fdn Trust Dept Haematol London England;

  ADC Therapeut Inc Murray Hill NJ USA;

  ADC Therapeut Inc Murray Hill NJ USA;

  Univ Calif San Diego Moores Canc Ctr Dept Hematol Oncol San Diego CA 92103 USA;

  Northside Hosp Blood &

  Marrow Transplant Program Atlanta GA USA;

  Greenville Hlth Syst Dept Hematol &

  Oncol Greenville SC USA;

  Emory Univ Sch Med Winship Canc Inst Dept Hematol &

  Med Oncol Atlanta GA USA;

  ADC Therapeut Amer Inc Murray Hill NJ USA;

  Columbia Univ Dept Med Ctr Lymphoid Malignancies New York NY USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词